Cisatracurium Besylate
- Product NDC
- 83634-655
- Requested package NDC
- 83634-655-20
- 11-digit product format
- 836340655
- Labeler code
- 83634
- Product ID
- 83634-655_53f69aa3-898e-476d-b18c-573487371a10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cisatracurium besylate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Avenacy, LLC
- Application
- ANDA216539
- Marketing category
- ANDA
- Marketing start
- 2026-08-15
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | |
| A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216539-001 | AP |
| A216539-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | 2024-08-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216539-001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216539-002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2024-08-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A216539-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A216539-002 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A216539-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A216539-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A216539-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A216539-002 | AP | 1 | caaa826d4ba7… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216539-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216539-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216539-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216539-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216539-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216539-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216539-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216539-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216539-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216539-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216539-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A216539-002 | AP | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216539-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216539-002 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cisatracurium Besylate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CISATRACURIUM BESYLATE | 10 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 80YS8O1MBS | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 199212 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1c6a8b98-deac-4e25-b4a0-5d0af5090281 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Avenacy, LLC | 1c6a8b98-deac-4e25-b4a0-5d0af5090281 | 2026-06-30 | Warnings, Adverse reactions | 216539 ANDA216539 83634-655-20 83634-655 83634065520 |
| Cisatracurium besylate | CISATRACURIUM BESYLATE | Slate Run Pharmaceuticals, LLC | 49185e78-d244-4426-90ef-ad109824eddb | 2024-08-29 | Warnings, Adverse reactions | 216539 ANDA216539 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 83634-655-20 | 83634065520 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-655-20) / 20 mL in 1 VIAL, SINGLE-DOSE (83634-655-41) | 2026-08-15 | No | No | Current |